Company News, Financial News

J&J To Separate Aveeno, Johnson’s and Neutrogena from Pharma and Medical Device Business

Move creates a consumer products business with sales of $15 billion, according to company.

Author Image

By: TOM BRANNA

Editor

Johnson & Johnson will separate the company’s Consumer Health business, creating a new publicly traded company. J&J is ranked No. 5 in Happi's The Top 50. The company's personal care sales were $7.6 billion last year. Corporate sales were $82.6 billion. J&J has leading positions in skin care, baby care and hair care. The move is expected to be completed by the end of 2022. According to J&J, the separation would create two global leaders that are better positioned...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters